Soleus Capital Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
NTCM
CCM
RIM
Soleus Capital Management's IRMD Position: Q3 2024 in Review
Soleus Capital Management sold out of iRadimed (IRMD) in Q3 2024, closing a stake of 102,067 shares — an estimated $4.48M sold.
Soleus Capital Management first reported a position in IRMD in Q4 2019 and held it in 19 quarters. The position peaked at $36.9M in Q2 2023. 144 funds tracked by Wall St. Rank hold IRMD as of Q3 2024.
- Soleus Capital Management reported no remaining iRadimed position as of Q3 2024 after selling out during the quarter.
- Soleus Capital Management sold 102,067 iRadimed shares in Q3 2024, an estimated $4.48M.
- Soleus Capital Management first reported a position in iRadimed in Q4 2019 and held it in 19 quarters.
- Soleus Capital Management's iRadimed position peaked at $36.9M in Q2 2023.
- 144 funds tracked by Wall St. Rank held iRadimed as of Q3 2024.
Based on Soleus Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.